NHI - National Health Investors Inc Stock Price, Fair Value and News

62.72USD+0.40 (+0.64%)Market Closed

Market Summary

USD62.72+0.40

Market Closed

0.64%

NHI Stock Price

View Fullscreen

NHI RSI Chart

NHI Valuation

Market Cap

2.7B

Price/Earnings (Trailing)

20.07

Price/Sales (Trailing)

8.51

EV/EBITDA

8.58

Price/Free Cashflow

14.76

NHI Price/Sales (Trailing)

NHI Profitability

EBT Margin

50.42%

Return on Equity

10.82%

Return on Assets

5.45%

Free Cashflow Yield

6.77%

NHI Fundamentals

NHI Revenue

Revenue (TTM)

319.8M

Rev. Growth (Yr)

12.45%

Rev. Growth (Qtr)

-0.8%

NHI Earnings

Earnings (TTM)

135.7M

Earnings Growth (Yr)

1.6K%

Earnings Growth (Qtr)

9.2%

Breaking Down NHI Revenue

Last 7 days

6.7%

Last 30 days

2.3%

Last 90 days

16.2%

Trailing 12 Months

26.7%

How does NHI drawdown profile look like?

NHI Financial Health

NHI Investor Care

Dividend Yield

5.74%

Dividend/Share (TTM)

3.6

Shares Dilution (1Y)

0.05%

Diluted EPS (TTM)

3.13

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	289.3M	307.2M	311.0M	319.8M
2022	289.2M	274.7M	277.2M	278.2M
2021	330.6M	320.8M	310.3M	298.7M
2020	325.1M	331.1M	333.7M	332.8M
2019	298.0M	303.1M	309.9M	318.1M
2018	285.0M	288.1M	291.7M	294.6M
2017	255.8M	264.5M	272.6M	278.7M
2016	232.3M	237.1M	242.1M	248.5M
2015	190.1M	202.3M	216.1M	229.0M
2014	133.9M	150.9M	164.6M	177.5M
2013	97.3M	103.5M	110.9M	117.8M
2012	87.6M	87.2M	89.0M	93.3M
2011	79.6M	82.0M	84.1M	86.2M
2010	68.3M	72.6M	73.8M	78.0M
2009	0	58.9M	60.8M	62.8M
2008	0	0	0	56.9M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of National Health Investors Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Feb 27, 2024	swafford charlotte a	bought	586,882	58.6882	10,000	-
Feb 23, 2024	gaines kristin sallee	acquired	-	-	3,000	svp/chief transaction officer
Feb 23, 2024	mendelsohn d. eric	acquired	-	-	3,000	ceo and president
Feb 23, 2024	spaid john l	acquired	-	-	3,000	cfo/evp finance
Feb 23, 2024	pascoe kevin carlton	acquired	-	-	3,000	chief investment officer
Feb 23, 2024	travis david l	acquired	-	-	3,000	svp/chief accounting officer
Oct 01, 2023	adams robert g	sold	-	-	-85,411	-
Aug 30, 2023	jobe james r	bought	51,398	51.3982	1,000	-
May 05, 2023	pascoe kevin carlton	acquired	-	-	4,000	chief investment officer
May 05, 2023	travis david l	acquired	-	-	4,000	svp/chief accounting officer

Which funds bought or sold NHI recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 22, 2024	MetLife Investment Management, LLC	reduced	-1.86	77,019	1,223,780	0.01%
Apr 22, 2024	Raymond James Financial Services Advisors, Inc.	reduced	-15.55	-86,449	1,643,300	-%
Apr 22, 2024	RAYMOND JAMES & ASSOCIATES	added	0.19	106,658	945,350	-%
Apr 19, 2024	REDMONT WEALTH ADVISORS LLC	sold off	-100	-549,073	-	-%
Apr 19, 2024	DENALI ADVISORS LLC	new	-	565	565	-%
Apr 19, 2024	State of Alaska, Department of Revenue	added	0.63	145,000	1,240,000	0.01%
Apr 19, 2024	Sumitomo Mitsui Trust Holdings, Inc.	added	9.87	4,893,900	25,625,500	0.02%
Apr 18, 2024	Park Place Capital Corp	unchanged	-	349	3,142	-%
Apr 18, 2024	Capital Advisors, Ltd. LLC	unchanged	-	-	-	-%
Apr 18, 2024	Allspring Global Investments Holdings, LLC	added	66.18	75,800	162,981	-%

Are Funds Buying or Selling NHI?

Are funds buying NHI calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NHI

No. of Funds

Unveiling National Health Investors Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	14.16%	6,146,344	SC 13G/A
Jan 08, 2024	blackrock inc.	10.0%	4,351,327	SC 13G/A
Feb 09, 2023	vanguard group inc	14.48%	6,281,653	SC 13G/A
Jan 24, 2023	blackrock inc.	9.8%	4,241,790	SC 13G
Feb 10, 2022	vanguard group inc	13.83%	6,343,120	SC 13G/A
Feb 01, 2022	blackrock inc.	9.9%	4,539,322	SC 13G/A
Feb 10, 2021	vanguard group inc	14.51%	6,488,920	SC 13G/A
Jan 08, 2021	blackrock inc.	10.0%	4,475,657	SC 13G/A
Feb 11, 2020	vanguard group inc	15.72%	6,912,043	SC 13G/A
Feb 05, 2020	blackrock inc.	9.5%	4,178,764	SC 13G/A

Recent SEC filings of National Health Investors Inc

View All Filings

Date Filed	Form Type	Document
Apr 18, 2024	PX14A6G	PX14A6G
Apr 04, 2024	ARS	ARS
Apr 04, 2024	DEF 14A	DEF 14A
Apr 04, 2024	DEFA14A	DEFA14A
Feb 28, 2024	4	Insider Trading
Feb 27, 2024	4	Insider Trading
Feb 27, 2024	4	Insider Trading
Feb 27, 2024	4	Insider Trading
Feb 27, 2024	4	Insider Trading
Feb 27, 2024	4	Insider Trading

Peers (Alternatives to National Health Investors Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
AMT	81.2B	11.1B	-9.63%	-14.57%	59.43	7.29	4.04%	-19.43%
CCI	41.5B	7.0B	-7.14%	-23.31%	27.61	5.94	-0.07%	-10.36%
AVB	26.8B	2.8B	3.01%	9.02%	28.86	9.68	6.73%	-18.30%
ARE	19.9B	3.0B	-4.73%	-3.60%	103.23	6.73	10.44%	-74.28%
AMH	12.9B	1.6B	-1.98%	8.50%	29.83	8.02	7.80%	39.39%
REG	11.1B	1.3B	1.26%	0.15%	30.42	8.39	8.04%	-24.50%
BXP	9.9B	3.3B	-0.65%	20.81%	51.88	3.01	5.31%	-77.32%
MID-CAP
FRT	8.5B	1.1B	3.35%	7.17%	36.02	7.54	5.38%	-38.52%
MAC	3.5B	884.1M	-4.94%	65.24%	-12.72	3.94	2.90%	-314.82%
SLG	3.4B	899.4M	-0.98%	126.14%	-6.02	3.78	-0.45%	-623.11%
SMALL-CAP
AAT	1.3B	441.2M	2.71%	21.12%	20.35	2.98	4.38%	15.77%
AIV	1.2B	198.2M	0.88%	3.60%	-7.42	5.71	-43.33%	-270.70%
MFA	1.1B	605.6M	-6.60%	4.26%	13.7	1.81	25.53%	134.62%
NYMT	656.9M	258.7M	3.60%	-29.41%	-13.5	2.54	0.11%	83.70%
IVR	415.3M	277.9M	-9.02%	-18.46%	-26.19	1.49	44.33%	96.06%

National Health Investors Inc News

Latest updates

National Health Investors Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-0.8%	79.00	80.00	78.00	82.00	71.00	76.00	60.00	71.00	70.00	74.00	74.00	81.00	81.00	84.00	84.00	83.00	82.00	82.00	78.00	76.00	74.00
Operating Expenses	-4.8%	50.00	52.00	50.00	50.00	69.00	57.00	50.00	66.00	69.00	62.00	41.00	44.00	39.00	41.00	39.00	43.00	39.00	39.00	38.00	40.00	37.00
S&GA Expenses	11.2%	5.00	4.00	4.00	6.00	5.00	5.00	5.00	8.00	3.00	4.00	4.00	8.00	3.00	3.00	3.00	4.00	4.00	3.00	3.00	4.00	3.00
EBITDA Margin	-2.0%	0.90*	0.92*	0.92*	0.97*	1.00*	1.01*	1.03*	0.99*	0.98*	0.95*	0.92*	-	-	-	-	-	-	-	-	-	-
Interest Expenses	-1.5%	15.00	15.00	14.00	14.00	12.00	11.00	11.00	10.00	12.00	13.00	13.00	13.00	12.00	13.00	14.00	14.00	14.00	15.00	14.00	14.00	13.00
EBT Margin	-2.7%	0.50*	0.52*	0.52*	0.56*	0.58*	0.58*	0.59*	0.56*	0.54*	0.52*	0.50*	-	-	-	-	-	-	-	-	-	-
Net Income	9.2%	32.00	29.00	40.00	34.00	2.00	34.00	22.00	8.00	6.00	31.00	39.00	35.00	37.00	43.00	44.00	-8.70	42.00	43.00	40.00	36.00	37.00
Net Income Margin	25.1%	0.42*	0.34*	0.36*	0.32*	0.24*	0.26*	0.25*	0.29*	0.37*	0.46*	0.48*	-	-	-	-	-	-	-	-	-	-
Free Cashflow	7.0%	53.00	50.00	50.00	31.00	46.00	44.00	57.00	39.00	53.00	49.00	52.00	-	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-0.4%	2,488	2,499	2,498	2,533	2,507	2,509	2,587	2,803	2,839	2,912	3,077	3,183	3,120	3,139	3,167	3,168	3,042	3,019	2,997	2,806	2,751
Cash Equivalents	34.8%	22.00	17.00	17.00	14.00	19.00	32.00	46.00	40.00	37.00	50.00	35.00	116	46.00	51.00	65.00	80.00	16.00	16.00	17.00	16.00	10.00
Net PPE	-0.6%	2,107	2,120	2,135	2,165	2,118	2,141	2,187	2,201	2,318	2,428	2,619	2,648	2,667	2,688	2,691	2,693	2,560	2,565	2,571	2,435	2,367
Liabilities	-0.3%	1,214	1,218	1,208	1,245	1,218	1,182	1,174	1,314	1,322	1,363	1,520	1,621	1,598	1,635	1,664	1,661	1,544	1,556	1,578	1,390	1,361
Shareholder's Equity	-0.5%	1,254	1,260	1,269	1,267	1,270	1,315	1,402	1,489	1,517	1,549	1,557	1,563	1,523	1,504	1,503	1,507	1,498	1,463	1,420	1,416	1,390
Retained Earnings	1.3%	2,467	2,435	2,405	2,366	2,331	-	-	-	-	-	-	-	-4.22	-4.22	-4.22	-4.22	-	-	-	-	-0.23
Additional Paid-In Capital	0.1%	1,604	1,603	1,602	1,601	1,599	1,598	1,598	1,596	1,591	1,590	1,589	1,594	1,541	1,511	1,505	1,505	1,506	1,467	1,419	1,407	1,370
Accumulated Depreciation	2.6%	673	656	639	626	612	599	593	582	577	593	623	618	598	577	556	535	514	495	488	469	451
Shares Outstanding	0%	43.00	43.00	43.00	43.00	43.00	45.00	46.00	46.00	46.00	46.00	46.00	-	-	-	-	-	-	-	-	-	-
Minority Interest	-3.3%	10.00	11.00	11.00	12.00	10.00	9.00	9.00	10.00	10.00	10.00	10.00	11.00	11.00	11.00	11.00	11.00	1.00	1.00	1.00	-	-
Float	-	2,166	-	2,166	-	2,581	-	2,581	-	-	-	2,938	-	-	-	2,581	-	-	-	3,496	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	7.0%	53,203	49,703	50,496	31,048	46,357	43,535	56,768	38,680	53,358	48,989	51,600	56,912	55,621	59,718	59,727	57,082	56,146	57,895	53,077	73,837	51,557
Share Based Compensation	-0.1%	865	866	769	2,105	1,037	1,065	1,428	5,083	988	989	992	5,446	289	457	470	1,845	691	477	477	2,001	359
Cashflow From Investing	111.7%	2,336	-19,946	33,501	-27,521	-49,198	54,920	194,283	-2,060	21,919	158,129	14,362	-9,133	-6,294	-3,293	-29,108	-51,017	-37,619	-36,873	-202,990	-65,039	-100,816
Cashflow From Financing	-61.8%	-49,417	-30,536	-80,250	-9,516	-7,357	-112,801	-244,919	-36,177	-85,987	-191,648	-147,465	22,106	-54,098	-70,729	-45,019	58,084	-19,139	-21,279	150,897	-3,156	51,207
Dividend Payments	0%	39,069	39,069	39,050	39,050	39,050	40,190	41,265	41,266	41,268	41,266	50,548	49,818	49,314	49,227	49,226	46,817	46,154	45,525	45,360	42,700	42,231
Buy Backs	-	-	-	-	-	-	81,974	69,977	-	-	-	-	-	-	-	-	-	-	-	-	-	-

NHI Income Statement

2023-12-31

Consolidated Statements of Income - USD ($) $ in Thousands	12 Months Ended
Consolidated Statements of Income - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues:
Rental income	$ 249,227	$ 217,700	$ 271,049
Resident fees and services	48,809	35,796	0
Interest income and other	21,799	24,698	27,666
Revenues	319,835	278,194	298,715
Expenses:
Depreciation	69,973	70,880	80,798
Interest	58,160	44,917	50,810
Senior housing operating expenses	39,587	28,193	0
Legal	507	2,555	908
Franchise, excise and other taxes	449	844	788
General and administrative	19,314	22,768	18,431
Taxes and insurance on leased properties	11,513	9,788	11,638
Loan and realty losses, net	1,376	61,911	52,766
Total operating expenses	200,879	241,856	216,139
Gain (loss) on operations transfer, net	20	(710)	0
Gain on note receivable payoff	0	1,113	0
Loss on early retirement of debt	(73)	(151)	(1,912)
Gains (losses) from equity method investment	555	569	(1,545)
Gains on sales of real estate, net	14,721	28,342	32,498
Other income	202	0	350
Net income (loss)	134,381	65,501	111,967
Add: net loss (income) attributable to noncontrolling interests	1,273	902	(163)
Net income attributable to stockholders	135,654	66,403	111,804
Less: net income attributable to unvested restricted stock awards	(57)	0	0
Net income attributable to common stockholders	$ 135,597	$ 66,403	$ 111,804
Weighted average common shares outstanding:
Basic (in shares)	43,388,794	44,774,708	45,714,221
Diluted (in shares)	43,389,466	44,794,236	45,729,497
Earnings per common share - basic (in usd per share)	$ 3.13	$ 1.48	$ 2.45
Earnings per common share - diluted (in usd per share)	$ 3.13	$ 1.48	$ 2.44

NHI Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($)
$ in Thousands

Dec. 31, 2023

Dec. 31, 2022

Real estate properties:

Land

$ 180,749

$ 177,527

Buildings and improvements

2,593,696

2,549,019

Construction in progress

5,913

3,352

Real estate properties, gross

2,780,358

2,729,898

Less accumulated depreciation

(673,276)

(611,688)

Real estate properties, net

2,107,082

2,118,210

Mortgage and other notes receivable, net of reserve of $15,476 and $15,338, respectively

245,271

233,141

Cash and cash equivalents

22,347

19,291

Straight-line rents receivable

84,713

76,895

Assets held for sale, net

5,004

Other assets, net

24,063

16,585

Total Assets

^[1]

2,488,480

2,507,424

Liabilities and Equity:

Debt

1,135,051

1,147,511

Accounts payable and accrued expenses

34,304

25,905

Dividends payable

39,069

39,050

Deferred income

6,009

5,052

Total Liabilities

^[1]

1,214,433

1,217,518

Commitments and Contingencies

Redeemable noncontrolling interest

9,656

9,825

National Health Investors, Inc. Stockholders' Equity:

Common stock

434

Capital in excess of par value

1,603,757

1,599,427

Retained earnings

2,466,844

2,331,190

Cumulative dividends

(2,817,083)

(2,660,826)

Total National Health Investors, Inc. Stockholders' Equity

1,253,952

1,270,225

Noncontrolling interests

10,439

9,856

Total Equity

1,264,391

1,280,081

Total Liabilities and Equity

$ 2,488,480

$ 2,507,424

[1]

The consolidated balance sheets include the following amounts related to our consolidated Variable Interest Entities (VIEs): $513.2 million and $519.8 million of Real estate properties, net; $10.9 million and $10.3 million of Cash and cash equivalents; $9.7 million and $7.1 million of Straight-line rents receivable; $9.4 million and $1.3 million of Other assets, net; and $4.7 million and $3.3 million of Accounts payable and accrued expenses as of December 31, 2023 and 2022, respectively.

About National Health Investors Inc

Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

CEO	Mr. D. Eric Mendelsohn
WEBSITE	nhireit.com
INDUSTRY	REIT Mortgage
EMPLOYEES	25

National Health Investors Inc Frequently Asked Questions

What is the ticker symbol for National Health Investors Inc? What does NHI stand for in stocks?

NHI is the stock ticker symbol of National Health Investors Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of National Health Investors Inc (NHI)?

As of Tue Apr 23 2024, market cap of National Health Investors Inc is 2.72 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NHI stock?

You can check NHI's fair value in chart for subscribers.

What is the fair value of NHI stock?

You can check NHI's fair value in chart for subscribers. The fair value of National Health Investors Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of National Health Investors Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NHI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is National Health Investors Inc a good stock to buy?

The fair value guage provides a quick view whether NHI is over valued or under valued. Whether National Health Investors Inc is cheap or expensive depends on the assumptions which impact National Health Investors Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NHI.

What is National Health Investors Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, NHI's PE ratio (Price to Earnings) is 20.07 and Price to Sales (PS) ratio is 8.51. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NHI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on National Health Investors Inc's stock?

In the past 10 years, National Health Investors Inc has provided 0.052 (multiply by 100 for percentage) rate of return.